Investors who lost money on Revance Therapeutics, Inc.(RVNC) should contact Levi & Korsinsky about pending Class Action – RVNC
(NasdaqGM:RVNC), NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Revance investors who were adversely affected by alleged securities fraud between February 29, […]